Swiss-based InVirtuoLabs raises 2.85M to accelerate drug development with AI - Silicon CanalsInVirtuoLabs secures €2.85M funding to reduce drug development time and costs, enhancing accessibility to treatments.
DeepMind CEO expects we'll pop AI-generated pills in 2025AI-designed drugs could enter clinical trials by the end of the year, potentially transforming drug development.
AI and the Level of Ordinary Skill: Why Patent Law Must (and Can) Adapt to AI-Augmented InventionAI tools are revolutionizing the capabilities of practitioners, demanding a reevaluation of patent law's concept of ordinary skill.
AI Model Predicts Dual Target DrugsAI is transforming biotechnology and pharmaceuticals by enabling the design of drugs that target multiple diseases simultaneously.
Using AI to repurpose existing drugs for treatment of rare diseases - Harvard GazetteAn AI tool called TxGNN can identify drug candidates for over 17,000 rare diseases, potentially addressing many previously untreated conditions.
Google Unveils A.I. for Predicting Behavior of Human MoleculesArtificial intelligence like AlphaFold accelerates protein understanding, drug discovery, and disease research.
Swiss-based InVirtuoLabs raises 2.85M to accelerate drug development with AI - Silicon CanalsInVirtuoLabs secures €2.85M funding to reduce drug development time and costs, enhancing accessibility to treatments.
DeepMind CEO expects we'll pop AI-generated pills in 2025AI-designed drugs could enter clinical trials by the end of the year, potentially transforming drug development.
AI and the Level of Ordinary Skill: Why Patent Law Must (and Can) Adapt to AI-Augmented InventionAI tools are revolutionizing the capabilities of practitioners, demanding a reevaluation of patent law's concept of ordinary skill.
AI Model Predicts Dual Target DrugsAI is transforming biotechnology and pharmaceuticals by enabling the design of drugs that target multiple diseases simultaneously.
Using AI to repurpose existing drugs for treatment of rare diseases - Harvard GazetteAn AI tool called TxGNN can identify drug candidates for over 17,000 rare diseases, potentially addressing many previously untreated conditions.
Google Unveils A.I. for Predicting Behavior of Human MoleculesArtificial intelligence like AlphaFold accelerates protein understanding, drug discovery, and disease research.
Google's new AI co-scientist aims to speed up the scientific discovery processGoogle's Gemini 2.0 AI co-scientist shows potential but faces skepticism regarding its innovative capabilities.
AI Finds Anti-Cancer Drug Candidates With Quantum ComputingAI and quantum computing can create novel anti-cancer drugs targeting previously untreatable proteins.
How A.I. Is Revolutionizing Drug DevelopmentThe laboratory at Terray Therapeutics utilizes miniaturized automation and AI for drug discovery, generating a massive amount of data daily.
Harnessing Hallucinations to Make AI More CreativeAI hallucinations can drive drug discovery breakthroughs by generating novel molecular structures.LLMs' errors expand scientific possibilities by enhancing human creativity in research.Rethinking AI flaws can reveal their potential as catalysts for innovation.
Deepmind scientist raises $50m to use AI in protein design revolutionLatent Labs aims to revolutionize protein design and drug discovery using AI technology developed by former DeepMind scientist Simon Kohl.
How techbio is shaking up pharmaTech disruptors aim to revolutionize drug discovery in the pharma sector using AI to improve efficiency and understanding of biology.
Google's new AI co-scientist aims to speed up the scientific discovery processGoogle's Gemini 2.0 AI co-scientist shows potential but faces skepticism regarding its innovative capabilities.
AI Finds Anti-Cancer Drug Candidates With Quantum ComputingAI and quantum computing can create novel anti-cancer drugs targeting previously untreatable proteins.
How A.I. Is Revolutionizing Drug DevelopmentThe laboratory at Terray Therapeutics utilizes miniaturized automation and AI for drug discovery, generating a massive amount of data daily.
Harnessing Hallucinations to Make AI More CreativeAI hallucinations can drive drug discovery breakthroughs by generating novel molecular structures.LLMs' errors expand scientific possibilities by enhancing human creativity in research.Rethinking AI flaws can reveal their potential as catalysts for innovation.
Deepmind scientist raises $50m to use AI in protein design revolutionLatent Labs aims to revolutionize protein design and drug discovery using AI technology developed by former DeepMind scientist Simon Kohl.
How techbio is shaking up pharmaTech disruptors aim to revolutionize drug discovery in the pharma sector using AI to improve efficiency and understanding of biology.
British professor makes thrilling' breakthrough for cancer that killed his motherA breakthrough in cancer research identifies a critical protein for chordoma treatment, offering new hope for effective therapies.
Orakl Oncology combines data and biology to bring new drugs to cancer patients | TechCrunchCancer incidence is increasing among younger adults, yet new drug trials often fail, highlighting the need for improved trial designs.
British professor makes thrilling' breakthrough for cancer that killed his motherA breakthrough in cancer research identifies a critical protein for chordoma treatment, offering new hope for effective therapies.
Orakl Oncology combines data and biology to bring new drugs to cancer patients | TechCrunchCancer incidence is increasing among younger adults, yet new drug trials often fail, highlighting the need for improved trial designs.
-Bond insertion reactions of two strained diradicaloids - NatureThe development of new synthetic methodologies enables the discovery of new medicines by offering alternative structures for aromatic compounds.
How AI uncovers new ways to tackle difficult diseasesAI is revolutionizing drug discovery, potentially reducing time and cost while increasing success rates for new treatments.
CEO of pharma giant Sanofi says businesses should stop 'AI washing'AI in healthcare has enormous potential, yet there is a trend of exaggeration by executives about its current capabilities.
Heart disease is the world's biggest killer - this Cambridge Uni spinout is using AI to find new treatments | TechCrunchAI is transforming drug discovery, particularly for cardiovascular diseases.CardiaTec raised $6.5 million to enhance cardiovascular disease treatments through AI.CVDs cause 17.9 million deaths annually, highlighting a major health crisis.
Cambridge startup analyses 'multi-omics' data to discover new heart drugsCardiaTec raises $6.5mn to enhance drug discovery for cardiovascular diseases using AI-driven multi-omics data analysis.
How AI uncovers new ways to tackle difficult diseasesAI is revolutionizing drug discovery, potentially reducing time and cost while increasing success rates for new treatments.
CEO of pharma giant Sanofi says businesses should stop 'AI washing'AI in healthcare has enormous potential, yet there is a trend of exaggeration by executives about its current capabilities.
Heart disease is the world's biggest killer - this Cambridge Uni spinout is using AI to find new treatments | TechCrunchAI is transforming drug discovery, particularly for cardiovascular diseases.CardiaTec raised $6.5 million to enhance cardiovascular disease treatments through AI.CVDs cause 17.9 million deaths annually, highlighting a major health crisis.
Cambridge startup analyses 'multi-omics' data to discover new heart drugsCardiaTec raises $6.5mn to enhance drug discovery for cardiovascular diseases using AI-driven multi-omics data analysis.
'Supermodel granny' drug extends life in animalsA drug increased lab animals' lifespan by 25% with potential for human aging; impact on inflammation control identified.
A 'Holy Grail' of Science Is Getting CloserThe complexity and vastness of human cells presents both challenges and opportunities for scientific research.
'Supermodel granny' drug extends life in animalsA drug increased lab animals' lifespan by 25% with potential for human aging; impact on inflammation control identified.
A 'Holy Grail' of Science Is Getting CloserThe complexity and vastness of human cells presents both challenges and opportunities for scientific research.
French biotech Generare speeds up hunt for new drugs by cloning natural molecules | TechCrunchGenerare raised €5 million to enhance its scalable methods for discovering natural compounds for drug development.
PhoreMost $12M Series B Financing to Advance Next-Gen Degrader ProgramsPhoreMost has raised $12 million in Series B funding, advancing its pipeline for oncology and inflammatory diseases.The company aims to move cancer treatment programs into preclinical development with this new funding.
Copenhagen's drug discovery firm Orbis Medicines raises 90MOrbis Medicines raised €90M in Series A funding to advance its innovative oral macrocycle drug discovery.
UK-based Exciting Instruments raises 4.7M in Seed fundingExciting Instruments raised £4M to enhance single-molecule detection technology, aiming for broader access in research and clinical applications.
French biotech firm Generare secures 5M - Silicon CanalsGenerare secures €5M funding to enhance biotechnology for drug discovery by leveraging microbial DNA.
French biotech Generare speeds up hunt for new drugs by cloning natural molecules | TechCrunchGenerare raised €5 million to enhance its scalable methods for discovering natural compounds for drug development.
PhoreMost $12M Series B Financing to Advance Next-Gen Degrader ProgramsPhoreMost has raised $12 million in Series B funding, advancing its pipeline for oncology and inflammatory diseases.The company aims to move cancer treatment programs into preclinical development with this new funding.
Copenhagen's drug discovery firm Orbis Medicines raises 90MOrbis Medicines raised €90M in Series A funding to advance its innovative oral macrocycle drug discovery.
UK-based Exciting Instruments raises 4.7M in Seed fundingExciting Instruments raised £4M to enhance single-molecule detection technology, aiming for broader access in research and clinical applications.
French biotech firm Generare secures 5M - Silicon CanalsGenerare secures €5M funding to enhance biotechnology for drug discovery by leveraging microbial DNA.
The conformational space of RNase P RNA in solution - NatureRNA conformational dynamics are crucial for various cellular functions and can inform drug discovery.
Photochemical permutation of thiazoles, isothiazoles and other azolesThe article discusses a new synthetic method using photochemical irradiation to modify thiazoles and isothiazoles, enhancing drug discovery capabilities.
Marie Curie Office Building / Proof of the SumPivot Park is a hub for open innovation in drug discovery, fostering collaboration and development in the pharmaceutical field.
Recursion to merge with Exscientia - Silicon CanalsThe merger between Recursion and Exscientia aims to combine their expertise to accelerate drug design and development.
Xaira, an AI drug discovery startup, launches with a massive $1B, says it's 'ready' to start developing drugs | TechCrunchBiotech investors tap into generative AI for drug discovery.
Recursion to merge with Exscientia - Silicon CanalsThe merger between Recursion and Exscientia aims to combine their expertise to accelerate drug design and development.
Xaira, an AI drug discovery startup, launches with a massive $1B, says it's 'ready' to start developing drugs | TechCrunchBiotech investors tap into generative AI for drug discovery.
Alphafold 3.0: the AI protein predictor gets an upgradeNuclear clocks are advancing, potentially providing a more accurate timekeeping system and insights into fundamental physics.
Daily briefing: Rejuvenating the immune system could slow ageingStudies show potential to treat immune ageing, cows as reservoir for bird flu, AlphaFold upgrade benefit for drug discovery.
Alphafold 3.0: the AI protein predictor gets an upgradeNuclear clocks are advancing, potentially providing a more accurate timekeeping system and insights into fundamental physics.
Daily briefing: Rejuvenating the immune system could slow ageingStudies show potential to treat immune ageing, cows as reservoir for bird flu, AlphaFold upgrade benefit for drug discovery.
Google, Isomorphic Labs brag about AlphaFold 3 modelAlphaFold 3 AI model by Isomorphic Labs predicts molecular structures with high accuracy, advancing drug discovery and research.
Google DeepMind's Groundbreaking AI for Protein Structure Can Now Model DNAGoogle enhances AlphaFold 3 for predicting biological molecules interactions.
Google, Isomorphic Labs brag about AlphaFold 3 modelAlphaFold 3 AI model by Isomorphic Labs predicts molecular structures with high accuracy, advancing drug discovery and research.
Google DeepMind's Groundbreaking AI for Protein Structure Can Now Model DNAGoogle enhances AlphaFold 3 for predicting biological molecules interactions.
Generative AI: Powering the next era of life sciences innovationsGenerative AI in life sciences landscape is poised to drive innovation, offering solutions for drug discovery, clinical trials, and manufacturing processes.
Generative AI will be designing new drugs all on its own in the near futureAI-driven molecule design can lead to novel drug candidates outside human imagination, pushing boundaries in medicine development.
Generative AI: Powering the next era of life sciences innovationsGenerative AI in life sciences landscape is poised to drive innovation, offering solutions for drug discovery, clinical trials, and manufacturing processes.
Generative AI will be designing new drugs all on its own in the near futureAI-driven molecule design can lead to novel drug candidates outside human imagination, pushing boundaries in medicine development.
The enigma of the rare genetic mutation that protects against cancer and heart attacksGenetic mutation in Ecuadorian families with Laron Syndrome protects from cardiovascular diseases, potential for drug discovery for aging-related diseases.
AI Is Transforming Drug Matching for Cancer, Rare Diseases | EntrepreneurAI tools are revolutionizing drug discovery for rare diseases by repurposing existing medications, leading to cost-effective and efficient screening processes.
Refining the impact of genetic evidence on clinical success - NatureHuman genetics is crucial in identifying potential drug targets but faces challenges in application to drug discovery.
ADMET-AI: A machine learning ADMET platform for evaluation of large-scale chemical librariesADMET-AI is a machine learning platform predicting drug properties like absorption, distribution, metabolism, excretion, and toxicity.Chemprop-RDKit uses a hybrid architecture to predict molecular properties, combining graph neural networks with feed-forward neural network layers.
EvolutionaryScale, backed by Amazon and Nvidia, raises $142M for protein-generating AI | TechCrunchEvolutionaryScale raised $142 million to build AI models for creating novel proteins in scientific research.
The foundation behind Ozempic maker Novo Nordisk is funding an Nvidia-backed AI supercomputer projectNovo Nordisk is investing in an AI supercomputer through collaboration with Nvidia for drug discovery and other scientific advancements.The Novo Nordisk Foundation's investment in the AI supercomputer is aimed at accelerating groundbreaking scientific discoveries and fostering collaboration between academia and industry.
EvolutionaryScale, backed by Amazon and Nvidia, raises $142M for protein-generating AI | TechCrunchEvolutionaryScale raised $142 million to build AI models for creating novel proteins in scientific research.
The foundation behind Ozempic maker Novo Nordisk is funding an Nvidia-backed AI supercomputer projectNovo Nordisk is investing in an AI supercomputer through collaboration with Nvidia for drug discovery and other scientific advancements.The Novo Nordisk Foundation's investment in the AI supercomputer is aimed at accelerating groundbreaking scientific discoveries and fostering collaboration between academia and industry.
Sick chimpanzees self-medicate using plants with medicinal propertiesChimpanzees in Uganda self-medicate with medicinal plants rich in antibacterial and anti-inflammatory properties, suggesting a potential for discovering new drugs through studying their behavior.